Xeris Biopharma CFO Steven Pieper disposes of 5,000 shares worth $42,500
XERS•CFO share sale under 10b5-1 plan
- Xeris Biopharma CFO Steven Pieper sold 5,000 common shares on Sep. 1, 2026 at $8.50 per share.
- Direct holdings fell to 1,356,053 shares following the sale.
- The trade was executed under a Rule 10b5-1 plan adopted on Aug. 18, 2025.




